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MetabolomicsThe mitochondrial prohibitin complex, composed of two proteins, PHB-1 and PHB-2, is a context-dependent
modulator of longevity. Speciﬁcally, prohibitin deﬁciency shortens the lifespan of otherwise wild type worms,
while it dramatically extends the lifespan under compromised metabolic conditions. This extremely intriguingly
phenotype has been linked to alterations in mitochondrial function and in fat metabolism. However, the true
function of the mitochondrial prohibitin complex remains elusive. Here, we used gas chromatography coupled
to a ﬂame ionization detector (GC/FID) and 1H NMR spectroscopy to gain molecular insights into the effect of
prohibitin depletion on the Caenorhabditis elegansmetabolome. We analysed the effect of prohibitin deﬁciency
in two different developmental stages and under two different conditions, which result in opposing longevity
phenotypes, namelywild typeworms and daf-2(e1370) insulin signalling deﬁcientmutants. Prohibitin depletion
was shown to alter the fatty acid (GC/FID) and 1H NMRmetabolic proﬁles of wild type animals both at the fourth
larval stage of development (L4) and at the young adult (YA) stage, while being more pronounced at the later
stage. Furthermore, wild type and the diapause mutant daf-2(e1370), either expressing or not prohibitin, were
clearly distinguishable based on their metabolic proﬁles, revealing changes in fatty acid composition, as well as
in carbohydrate and amino acid metabolism. Moreover, the metabolic data indicate that daf-2(e1370)mutants
are more robust than the wild type animals to changes induced by prohibitin depletion. The impact of prohibitin
depletion on the C. elegansmetabolomewill be discussed herein in the scope of its effect on longevity. This article
is part of a Special Issue entitled: Mitochondrial Dysfunction in Aging. Guest Editor: Aleksandra Trifunovic
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The nematode Caenorhabditis elegans has been extensively used to
gain insights into the complex process of ageing and it has been ex-
tremely useful in the identiﬁcation of mutations leading to increased
longevity [1,2]. Research has led to remarkable progress in describing
themolecular pathways that modulate ageing, including several signal-
ling cascades, among them, the most prominent one being the insulin/
insulin-like signalling (IIS) pathway [3]. One universal hallmark of
ageing is themarked alterations in cellular energymetabolism [4]. Con-
sistently, the biogenesis and function of mitochondria, the energy-
generating organelles in eukaryotic cells, are primary longevity deter-
minants [5]. Recently, the mitochondrial prohibitin complex washondrial Dysfunction in Aging.
. This is an open access article undershown to differentially modulate longevity depending on intrinsic and
extrinsic cues [6].
The mitochondrial prohibitin complex is composed of two proteins,
PHB-1 and PHB-2, which bind to each other to form a heterodimer that
is assembled into a ring-like macromolecular structure at the inner mi-
tochondrial membrane [7]. These two subunits are interdependent for
the formation of the complex, leading the absence of one of them to
the absence of the whole complex [8–10]. Although different cellular
functions have been suggested for both PHB-1 and PHB-2 in other cellu-
lar compartments, several evidences points to prohibitins functioning
together within mitochondria (reviewed in [11,12]). Several roles
have been proposed for the mitochondrial prohibitin complex, includ-
ing a role as a membrane-bound chaperone, which holds and stabilizes
newly synthesised mitochondrial-encoded proteins [13,14] and as scaf-
fold proteins that recruit membrane proteins to a speciﬁc lipid environ-
ment [15,16]. Prohibitins have also been ascribed to different cellular
processes such as cellular proliferation, cancer and ageing (reviewed
in [12]). Prohibitin depletion delays development, reduces body size
and gives rise to awide range of somatic and germline defects, spanningthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ically abnormal somatic gonad [6,8]. Intriguingly, prohibitin deﬁciency
results in opposite ageing phenotypes depending on the metabolic sta-
tus, being this phenotype evolutionarily conserved [6,17]. In particular,
prohibitin deﬁciency shortens the lifespan of otherwise wild type nem-
atodes, while it dramatically extends the lifespan of the already long-
lived daf-2(e1370) insulin receptor mutants [6].
DAF-2, an orthologue of the insulin/insulin-like growth factor recep-
tor, modulates the activity of the IIS pathway, through the FOXO tran-
scription factor DAF-16 [18,19]. DAF-16 is required for reproductive
growth andmetabolism, as well as normal lifespan, responding to envi-
ronmental cues, such as nutritional status or growth conditions [20,21].
Moreover, it regulates the entrance and exit into an alternative develop-
mental stage, the diapause stage, characterised by extremely high resis-
tance and survival to harsh conditions [20]. The diapause mutant daf-2
is characterised by alterations in its metabolism, namely at the level of
the glyoxylate shunt and gluconeogenesis [22,23]. Indeed, one plausible
mechanism for the increased longevity of daf-2 mutants involves its
tuning of cellularmetabolism towardsmaximal survival [23]. Neverthe-
less, how these metabolic shifts towards maximal survival occur, and
how, if at all, they contribute, remains largely unknown. Interestingly,
the modulation of lifespan by prohibitin is accompanied by alterations
in the levels of fat content, as measured by different staining methods
[6]. Additionally, prohibitin deﬁciency extends the lifespan of nhr-49
mutant. NHR-49 is a key regulator of fat mobilization, modulating fat
consumption and maintaining a normal balance of fatty acid composi-
tion [6]. In C. elegans up to 35% of the dry body mass is composed by
lipids, from which 40–55%, depending on the diet and growth stage,
are the fat stores triglycerides, esters derived from glycerol and three
fatty acids [24,25]. Fat visualization using dyes, apart from the contro-
versy onwhat these dyes are really staining [26], does not allow the dis-
tinction of the different lipid composition. Thus, a more direct way of
examining the lipid composition upon prohibitin depletion and, in a
broader perspective, a global view of the effect of prohibitin on the
C. elegansmetabolome is missing.
In recent years, the advances of different analytical platforms have
allowed the development of the ﬁeld of metabolomics. Metabolomics
focus on the analysis of all the metabolites, the metabolome, of biologi-
cal systems. However, the physicochemical diversity of the metabolites
makes virtually impossible, even with all the advances made so far, to
consider them all at the same time with a single strategy [27]. Instead,
just to get near to its ultimate goal, a combination of different analytical
methods and different metabolite extraction procedures must be used
[27]. Application of a multitude and complementary metabolomics ap-
proaches will allow the gathering of molecular data that ultimately
will led to a better understanding of the ageing process.
We present herein the ﬁrst broad characterisation of the metabolic
modiﬁcations induced by prohibitin depletion both in wild type and
in daf-2(e1370) mutants. For that purpose, analysis of the fatty acid
composition using gas chromatography coupled to a ﬂame ionization
detector (GC/FID) and 1H NMR metabolic proﬁling of whole worms
was conducted. Prohibitin deﬁciency was found to induce a broad
reorganization of the metabolic network in both wild type and
daf-2(e1370) mutants, and these ﬁndings will be discussed in the scope
of the observed effect of prohibitin on the worm lifespan expectancy.
2. Material and methods
2.1. Strains, worm culture and sampling conditions
Nematodes were cultured and maintained according to standard
methods at 20 °C. The strains N2, wild type Bristol isolate, and
CB1370, daf-2(e1370)III, were used in this study. Synchronous animal
populationswere generated by hypochlorite treatment of gravid adults.
Tightly synchronised embryos were obtained by allowing eggs to hatch
and develop until L1 larval stage in S Basal during overnight incubation.The worms were then fed with HT115 (DE3) Escherichia coli bacteria
(deﬁcient for RNase-E), harboring the appropriate RNAi plasmids
(pL4440 for control RNAi, pL4440 containing a phb-1 or a phb-2 geno-
mic fragment for RNAi knockdown of either phb-1 or phb-2, respective-
ly). Each bacterial strain was inoculated, from an overnight pre-
inoculum, in LB (carbenicillin (25 mg/l) (Sigma) and tetracycline
(15 mg/l) (Sigma)) to an initial OD600 nm of approximately 0.2 and
grown until it reached an OD600 nm of approximately 1.5 (37 °C). IPTG
(Sigma) was then added to the bacterial culture (1 mM). The bacterial
culture was incubated for 2 h (37 °C) and then harvested by centrifuga-
tion at 3200 ×g (4 °C) for 20 min. Pellets were washed with S Basal
(4 °C) and harvested again (3200 ×g, 20 min and 4 °C). Finally, bacterial
stocks were prepared by resuspending the pellets (30 g/l) in S Medi-
um containing carbenicillin (25 mg/l), IPTG (1 mM) and cholesterol
(5 mg/l) (Sigma), and kept at 4 °C at most 4 days before being used.
The effectiveness of RNAi against phb-1 or phb-2 was checked pheno-
typically by the worm sterility (data not shown). To assess the effect
of either phb-1 or phb-2 deﬁciency on the whole worm GC/FID and 1H
NMR proﬁles, synchronous populations of N2 wild type worms (ap-
proximately 2 worms/μl) were grown in liquid medium and sampled
(approximately 30,000 worms) at either L4 larval or young adult (YA)
stages. To compare the effect of prohibitin deﬁciency on the GC/FID
and 1H NMR proﬁles of wild type and daf-2(e1370) worms, synchro-
nous populations were grown on agar plates seeded with the
appropriate bacteria (control RNAi or phb-1(RNAi)) and sampled (ap-
proximately 10,000 worms) at the YA stage. Sampled worms were
washed six times (three with S Basal, two more with double distilled
water and a sixth time with MS-grade water (Fluka)), harvested after
each washing step by centrifugation at 800 ×g for 1 min (20 °C) and
the ﬁnal worm pellet was snap-frozen in liquid nitrogen and kept in
the freezer (−80 °C) until further use.
2.2. GC/FID analysis
To determine the overall fatty acid composition of the nematodes,
lipids were extracted using an adaptation of the methyl-tert-butyl
ether lipid extraction procedure [28]. Brieﬂy, 1.5 ml of cold (−25 °C)
MS-grade methanol (Sigma) was added to the frozen worm pellet
(200 μl) and transfer to a 10 ml glass vial. Worms were broken up by
sonication (SONOPLUS 2070; 20 cycles of 1 min at maximum power
followed by a pause of 15 s to make sure the mixture was maintained
cold) in a cold ethanol bath (between −20 °C and −30 °C). After,
5 ml of methyl tertiary-butyl ether (MTBE) (Sigma) was added to this
mixture, vortexed slightly and incubated for 1 h at 20 °C in a shaker.
Phase separation was induced by adding 1.25 ml of MS-grade water
(Fluka), vortexed slightly and, upon 10 min of incubation (20 °C), cen-
trifuged at 1000 ×g for 10 min (20 °C). The upper phase (organic
phase) was collected, while the lower phase was re-extracted with
2 ml of MTBE/methanol/water (10:3:2.5, v/v/v). Both organic phases
were then combined and kept in the freezer (−25 °C) until further use.
After lipid extraction, each sample was derivatised to make it ame-
nable to be analysed by gas chromatography coupled to a ﬂame ioniza-
tion detector (GC/FID). First, the sample was evaporated in nitrogen
atmosphere until dryness. To release the fatty acids of complex lipids
and methylate them, 1 ml of hydrogen chloride (HCl)-methanol
(1.25 M HCl) (Sigma) was added and kept in a bath at 80 °C for 1 h.
Two phases were then obtained by the addition of 3 ml of hexane
(Sigma) and 1.5 ml of Na2SO4 (6.7% m/v) (Sigma). Finally, the fatty
acid methyl esters (FAMEs) were obtained by transferring the upper
phase to another tube, where it was evaporated in the same conditions
as before. In the end, 150 μl of heptane (Sigma) was added, FAMEs were
resuspended and transferred to a vial with an insert for the GC/FID
analysis and injected to the GC. The samples were analysed in a
gas chromatograph (Perkin Elmer Clarus 500) equipped with a
0.2 μm × 60 m × 0.25 mm fused silica capillary column, hydrogen at
45 ml min−1 was employed as carrier gas and coupled to a ﬂame
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tial temperature of 140 °C (hold for 2 min), followed by an increase of
10 °C min−1 to 210 °C (hold for 7 min). Also set were the following pa-
rameters: 270 °C inlet and 280 °C detector temperatures. To assign the
peaks in the spectral data, a standard mixture with known composition
of FAMEs (Sigma) was previously run in the same conditions, and the
assignment was done based on the retention time and the area of the
peaks.
2.3. 1H NMR metabolic proﬁling
To obtain the metabolic proﬁle of whole worm extracts, metabolites
were extracted using an adaption of hot ethanol extraction proce-
dure [29]. In short, 1.0 ml of cold (−25 °C) MS-grade ethanol (Merck)
was added to the worm pellet (200 μl) and transferred to a 10 ml
glass vial. Worms were broken up by sonication using the same proce-
dure described before for the GC/FID analysis. The broken worms
were centrifuged for 3 min at 3200 ×g in a centrifuge previously cooled
to−10 °C and the supernatant was kept on cold. Hot ethanol (80 °C)
was added to the pellet (0.75 ml of 75% ethanol (v/v)), vortexed for
15 s, incubated for 3 min at 80 °C, and vortexed again for 15 s. The
mixture was centrifuged again for 3 min at 3200 ×g. This process was
done two times and the three supernatants were joined together. The
samples were concentrated under vacuum and kept in the freezer
(−80 °C) until NMR data acquisition.
The samples were analysed using a 600 MHz Bruker spectrometer,
equipped with a 5-mm cryogenically-cooled TCI probe (1H, 15N, 13C),
at 298.15 K. Brieﬂy, the dried extracts were dissolved in 0.7 ml of buffer
(0.1 M phosphate buffer pH 7.00, in D2O, containing 0.1 mM of
trimethylsilyl-2,2,3,3-tetradeuteropropionate (d4-TSP)), centrifuged at
16,000×g for 10min and the supernatantwas transferred into 5mmdi-
ameter NMR tubes. One-dimension (1D) proton spectra were acquired
at constant gain, with 256 transients and a spectral width of 20 ppm. A
train of Carr–Purcell–Meiboom–Gill (CPMG) echoes, of 40ms long, was
used to reduce macromolecules broad signals. During the 4 s relaxation
delay, the residual water peak was pre-saturated. All proton spectra
were manually phased, baseline corrected and referenced to d4-TSP (δ
0.00 ppm) using the program Mnova v9 for NMR data processing. To
aid in metabolite identiﬁcation, 2D J-resolved (relaxation delay of 2 s,
64 increments and 8 transients), Total Correlation Spectroscopy
(TOCSY; relaxation delay of 1.5 s, 256 increments and 16 transients)
and Heteronuclear Single Quantum Coherence (HSQC; relaxation
delay of 1.5 s, 360 increments and 88 transients) spectra were collected
for representative samples.
2.4. Data analysis
For each GC/FID spectrum, the areas of the assigned peaks were
calculated and normalised to their total area. All spectra were put in a
data table form and imported into the software SIMCA v13.0.3.0 for
multivariate data analysis. Regarding the 1H NMR data, the regions cor-
responding to residual water and ethanol (5.00–4.665, 3.70–3.63 and
1.21–1.15 ppm) were excluded. Each spectrum was integrated over a
series of ﬁxedwidth bins (0.005 ppm) usingMnova v9 features. All pro-
ton spectra were normalised to the total intensity between 9.70 and
0.70 ppm, put in a data table form and imported into the software
SIMCA v13.0.3.0 for multivariate data analysis.
In SIMCA v13.0.3.0 both GC/FID and 1H NMR data were pre-
processed using Pareto scaling, and analysed using principal component
analysis (PCA) and orthogonal partial least squares discriminant analy-
sis (O-PLS-DA). PCA, an unsupervised method, was used to get an over-
view of the data structure, to observe clustering or separation trends.
R2X and Q2 (calculated by 7-fold internal cross-validation) values
were considered as measures of goodness of model and the model ro-
bustness, respectively. R2X is the total variance explained by the set of
principal components (PCs) of the model, and cross validation of eachcomponent will provide the Q2, which describes the total variation pre-
dicted by the model's PCs. The value of Q2 ranges from 0 to 1 and typi-
cally a Q2 value greater than 0.4 is considered a good model, and those
with Q2 values over 0.7 are robust. O-PLS-DA, a supervised method
that uses prior information, was used to better discriminate between
clusters. Evaluation of the supervised models were based on the R2X,
Q2, and also using the goodness-of-ﬁt parameter R2Y (variation in
class membership explained by themodel). In the O-PLS-DA, a measure
of the degree to which a particular variable explains cluster member-
ship was obtained with the variable importance in projection for inde-
pendent variables (VIP) plot (with conﬁdence intervals derived from
jack kniﬁng routine). A VIP value above 1 indicates that a given variable
is important for classmembership. Identiﬁcation ofmetabolites respon-
sible for the cluster separation (variables combining high model inﬂu-
ence with high reliability) was also done using the predictive S-line
plot (a way to visualize both the covariance and the correlation struc-
ture between the X-variables and the predictive score).
Univariate statistical analysis was performed in excel. The relative
abundances of the assigned peaks in the GC/FID data and the relative
abundances of the characteristic bins (bins more characteristic of each
speciﬁc metabolite) in the NMR data were analysed using two-sample
for mean Student's t-test (unpaired, two tails and unequal variances).
P-values of b0.05 were considered to be statistically signiﬁcant.
3. Results
3.1. Prohibitin depletion alters the fatty acid composition of wild type
worms
Prohibitin depletion strongly alters C. elegans fat content as indicated
by a variety of bothﬁxed and live stainingmethods [6]. Here,we initially
asked if the mitochondrial prohibitin complex modulates the worm
fatty acid composition by analysing the effect of depleting either phb-1
or phb-2 by RNA interference (RNAi). We analysed an organic fraction
of the metabolome of wild type animals depleted of either prohibitin
subunit at two developmental stages, the fourth larval stage of develop-
ment (L4) and young adults (YA). The GC/FID analysis from whole
worm extracts enabled the detection of several peaks, 13 of which
were assigned and included in the multivariate analysis (Fig. 1;
Table S1). Principal component analysis (PCA) evidences that along de-
velopment the fatty acid composition changes in a prohibitin-
dependent manner (Fig. 1B). Prohibitin-depleted worms (phb-1(RNAi)
and phb-2(RNAi)) at the young adult stage appear more distant apart
from wild type worms (control RNAi) than at the fourth larval stage of
development (Fig. 1B). PCAmodelling of either L4 or YA data sets sepa-
rately makes this ﬁnding clearer (Fig. 1C and D). At the L4 stage, al-
though the separation is still not completely clear, it is visible a
distinction between wild type and prohibitin-depleted worms across
principal component 2 (PC2) (Fig. 1C). Remarkably, the difference be-
tween wild type and prohibitin-depleted worms is more evident at
the YA stage, clearly separated across PC1, while no clear separation is
visible between phb-1 or phb-2 depleted worms (Fig. 1D). The dendro-
grams derived from the supervised models, using orthogonal partial
least squares discriminant analysis (O-PLS-DA), clearly show that the
two clusters (wild type and prohibitin-depleted worms) are more dis-
tant apart at the YA than at the L4 stage, as shown by the distance in
the dendrograms (Fig. 1E and F). The supervised modelling at the YA
stage pointed C20:5n3 and C20:4n3 as the fatty acids contributing
more for cluster separation. The content of these two fatty acids is clear-
ly lower in prohibitin deﬁcientworms at theYA stage (Fig. 2; Table S1B).
Besides these two fatty acids, C20:3n6 and C18:2n6cwere also found to
be reduced in prohibitin-depleted worms, while C18:1n9c, C16:1,
C16:0, C14:1 and C14:0 were found to be increased upon prohibitin de-
pletion (Fig. 2; Table S1B). Overall, RNAi targeting either phb-1 or phb-2
results in similar altered fatty acid composition, likely due to depletion
of the whole PHB complex. In particular, prohibitin depletion in
Fig. 1.Multivariate analysis of the fatty acid composition of wild type worms upon prohibitin depletion. (A) Typical GC/FID spectrum of whole worm extracts. (B) Score plot derived from
the PCA modelling (5 PCs, R2X = 0.948 and Q2 = 0.616) of the GC/FID data of wild type animals depleted of either phb-1 or phb-2 (control RNAi, phb-1(RNAi) and phb-2(RNAi)) at two
developmental stages (fourth larval stage (L4) and young adults (YA)). (C and D) Score plots of the PCAmodel at the L4 stage (2 PCs, R2X= 0.812 and Q2= 0.579) and at YA stage (1 PC,
R2X = 0.615 and Q2 = 0.433), respectively. (E and F) Dendrograms derived from the O-PLS-DA modelling of GC/FID data at the L4 stage (1 + 2 + 0 PCs, R2X = 0.886, R2Y = 0.852 and
Q2 = 0.741) and at the YA stage (1 + 1 + 0 PCs, R2X = 0.743, R2Y = 0.929 and Q2 = 0.89) respectively.
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chain and saturated fatty acids, with the concomitant decrease of long
chain and unsaturated fatty acids.
3.2. 1H NMR reveals clear changes in the metabolic proﬁles of wild type
worms upon prohibitin depletion
We then asked if the effect of prohibitin propagates more broadly
over the worm metabolic network. To address this question, we
undertook a metabolic proﬁling strategy by 1H NMR spectroscopy of
wholewormextracts.Wild typeworms, grown in liquidmedium, either
expressing (control RNAi) or not (phb-1(RNAi) or phb-2(RNAi))
prohibitin were sampled at two developmental stages (L4 and YA). De-
spite many resonances remained unassigned, a wide range of classes of
biomolecules were identiﬁed, including amino acids (e.g. alanine and
asparagine), cofactors (NAD+ andNADP+), sugars (e.g. glucose and tre-
halose) and organic acids (e.g. succinic and fumaric acids) (Fig. S1). Me-
tabolite identiﬁcation was done by a careful analysis of the chemical
shifts, intensities, J couplings and multiplicities of the peaks present in
the one dimensional 1H NMR spectra, together with information from
J-resolved, TOCSY and HSQC spectra, and complemented with datagathered in different databases [30,31]. PCA of the NMR data evidences
the existence of four main clusters (Fig. 3A). Namely, wild type worms
at the L4 larval stage, wild type worms at the YA stage, prohibitin-
depleted worms (phb-1(RNAi) and phb-2(RNAi)) at the L4 stage, and
prohibitin-depleted worms at the YA stage (Fig. 3A). Similarly to the
GC/FID data, PCA modelling of either L4 or YA data sets separately did
not evidence any clear separation between worms depleted of either
phb-1 or phb-2, and evidence a clear distinction between wild type
and prohibitin-depleted worms both at the L4 and YA stages (Fig. 3B
and C). Moreover, the difference between wild type and prohibitin-
depleted worms is higher at the YA than at the L4 stage, as shown by
the distance between the clusters in the dendrograms derived from
the supervised models (Fig. 3D and E). From the supervised model we
were able to identify as the strongest contributors for cluster separation
at the YA stage the metabolites alanine and trehalose, with an increase
in their content, and glycerol and valinewith a decrease in their content
upon prohibitin depletion (Fig. 4A and B; Table S2). Altogether, the 1H
NMRmetabolic proﬁling ofwild typeworms revealed a broadmetabolic
reorganization, at level of both carbohydrate and amino acid metabo-
lism, upon prohibitin depletion, which may partially contribute for the
pleiotropic effect of prohibitin depletion in the physiology of C. elegans.
Fig. 2. Fatty acid composition ofwild typeworms upon prohibitin depletion. Fatty acids showing analtered content at the young adult stage in a prohibitin-dependentmanner are depicted
(t-test, P-value b 0.05).
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composition of wild type worms than of daf-2(e1370) mutants
Prohibitin deﬁciency differentially modulates fat content in wild
type and in daf-2(e1370)mutant animals [6]. To gainmolecular insights
associated with these differences, we inquire if prohibitin modulates
fatty acid composition in a genetic background-speciﬁc manner. To
achieve this, wild type and daf-2(e1370)worms either expressing (con-
trol RNAi) or not (phb-1(RNAi)) prohibitin were grown on agar plates
and sampled at the YA stage. Prohibitin depletion in otherwise wild
type worms results in a developmental delay, reaching the YA stage ap-
proximately 60 h after the L1 larval stage, as compared to 46 h on con-
trol RNAi. On the other hand, the daf-2(e1370) mutant takes 70 h to
reach the YA stage on control RNAi, while on phb-1(RNAi) it takes
94 h. The conditions were set based on the previous results, which
showed that RNAi targeting either phb-1 or phb-2 had a similar effect
on the fatty acid composition of wild type worms, being these alter-
ations more pronounced at the YA stage (Fig. 1). Finally, worms were
grown on plate due to the higher frequency of daf-2(e1370)worms en-
tering the dauer stage when grown in liquid medium, especially when
feeding on phb-1(RNAi) bacteria, andmore generally due to the difﬁcul-
ties to interpretmetabolic and longevity analysis fromworms subjected
to the stresses present in liquid medium (reviewed in [32]). The GC/FID
data indicate that depletion of prohibitin alters the fatty acid composi-
tion of both wild type and daf-2(e1370) worms grown on plate (Fig. 5
and Table S3). PCA modelling shows that wild type, phb-1(RNAi), daf-
2(e1370) and daf-2(e1370); phb-1(RNAi) animals at the YA stage are
clearly distinguishable across PC1 (Fig. 5A), indicating that fatty acid
composition differs between wild type and daf-2(e1370) worms, and
that in both cases it is altered, with the same general trend, upon
prohibitin depletion. The effect of prohibitin depletion is more pro-
nounced in wild type animals than in daf-2(e1370)mutant worms, as
shown by the distance in the dendrograms derived from the supervised
models (Fig. S2B and D). Nevertheless, the alteration in the fatty
acid composition induced by prohibitin depletion in both genetic
backgrounds is smaller than the differences between the two genetic
backgrounds (Figs. 5A and S2). Compared to wild type worms, daf-2(e1370) mutants have a higher content of C14:0, C14:1, C16:1, and
C18:2n6c and a lower content of C18:0, C20:0, C20:3n6, C20:4n6,
C20:4n3 and C20:5n3 (t-test, P-value b 0.05) (Table S3).Most of the ob-
served differences between wild type and daf-2(e1370)mutants are in
agreement with previously published results [33], which reﬂect, a gen-
eral increase in short chain and saturated fatty acids and a decrease in
long chain and more unsaturated fatty acids. Prohibitin depletion in
daf-2(e1370) mutants further increases the content of C16:1 and
C18:2n6c while it further reduces the content of C20:0, C20:3n6,
C20:4n3 and C20:5n3 (t-test, P-value b 0.05) (Fig. 5B; Table S3). Collec-
tively, and similar to the phenotype observed in wild type worms,
prohibitin depletion in daf-2mutants leads to a decrease in the content
of long chain and unsaturated fatty acids, with the concomitant increase
in the content of short chain and saturated fatty acids.
3.4. 1H NMR metabolic proﬁles reveal more dramatic changes in wild type
worms than in daf-2(e1370) mutants upon prohibitin depletion
The broad alteration of the metabolic proﬁle observed in wild type
worms upon prohibitin depletion, prompted us to examine its effect
on the 1H NMR proﬁle of daf-2mutant animals.We analysed the chang-
es in the metabolic proﬁles of wild type and daf-2(e1370) either ex-
pressing (control RNAi) or not (phb-1(RNAi)) prohibitin. Worms were
grown on solidmedia and analysed at the YA stage. Prohibitin depletion
alters themetabolic proﬁles of both wild type and daf-2(e1370)worms,
as seen in the PCAmodel (Fig. 6A), which shows a clear separation of the
four groups of samples across PC1. Prohibitin depletion induces smaller
changes on the metabolic proﬁle of daf-2(e1370)mutants than of wild
type animals, as indicated by the distance in the dendrograms derived
from the supervised models (Fig. S3B and D). Similar to what was ob-
served on the fatty acid composition, the changes induced by prohibitin
depletion are smaller than the differences on the metabolic proﬁles be-
tween the two genetic backgrounds (Figs. 6A and S3). The content of
leucine, valine, glutamate, succinate, beta-alanine, aspartate, ornithine,
threonine and phenylalanine was found to be lower, while the content
of glutamine, asparagine, arginine, glycine, glycerol, trehalose and allan-
toin was found to be higher in prohibitin-depleted worms (t-test, P-
Fig. 3. 1H NMRmetabolic proﬁling ofwild typeworms upon either phb-1 or phb-2 depletion. (A) 3D score plot derived from the PCAmodelling (4 PCs, R2X=0.732 and Q2=0.581) of the
1HNMRdata (control RNAi, phb-1(RNAi), phb-2(RNAi) at twodevelopmental stages (fourth larval stage of development (L4) and young adult (YA) stages)). Score plots of the PCAmodel at
L4 stage (B) (3 PCs, R2X= 0.726 and Q2= 0.398) and at YA stage (C) (2 PCs, R2X= 0.622 and Q2= 0.438). Dendrograms derived from the O-PLS-DAmodelling of the 1H NMR data at L4
stage (D) (1 + 1 + 0 PCs, R2X = 0.605, R2Y = 0.926 and Q2 = 0.854) and at YA stage (E) (1 + 1 + 0 PCs, R2X = 0.619, R2Y = 0.98 and Q2 = 0.948).
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worms and daf-2(e1370)mutants fed on control RNAi showed that the
later has higher content of betaine, threonine, trehalose and allantoin,
while wild type animals have higher content of leucine, valine, lactate,
glutamate, glutamine, succinate, beta-alanine, aspartate, lysine, orni-
thine, glycine, tyrosine, phenylalanine and tryptophan (t-test, P-
value b 0.05) (Fig. 6B and Table S4). Most of these differences are in
agreement with previously published data [33]. Additionally, and simi-
lar to its effect onwild typeworms, prohibitin depletion in daf-2(e1370)
mutants leads to a decrease in the content of glutamate, beta-alanine,
threonine and phenylalanine, while it leads to an increase in the content
of glutamine and trehalose (t-test, P-value b 0.05) (Fig. 6B and Table S4).
On the other hand, depletion of prohibitin had an opposing effect in the
content of alanine in the two genetic backgrounds, which lead to a sig-
niﬁcant difference between the two genetic backgrounds fed on phb-
1(RNAi). Although not statistically signiﬁcant, wild type worms have
higher content of alanine than daf-2mutants. However, the content of
alanine is further increased upon prohibitin depletion in wild type
worms and further decreased in daf-2 mutants, which results in daf-2(e1370)mutants fed on phb-1(RNAi) having a signiﬁcant lower con-
tent of alanine than prohibitin depleted otherwise wild type worms
(Fig. 6B and Table S4). The alterations in the levels of alanine show an
inverse trendwith the longevity of theworms, whichmight be relevant
when considering that the same inverse correlation between alanine
content and yeast chronological lifespan has been previously reported
[34]. A similar behaviour in the content of lactate was also observed
(Fig. 6B and Table S4). Overall, prohibitin depletion had a more pro-
nounced effect on the metabolic proﬁle of wild type worms than of
daf-2(e1370) mutants indicating that daf-2 mutants are more robust
to the changes elicited upon prohibitin depletion, and which may ac-
count to some extent for the opposing effect of prohibitin on the
worms longevity.
4. Discussion
The mitochondrial prohibitin (PHB) complex is composed of about
12 to 16 heterodimers, each constituted by two subunits, PHB-1 and
PHB-2. Both subunits are interdependent for the formation of the
Fig. 4.Metabolites showing an altered content in a prohibitin-dependentmanner. (A) S-line plot from theO-PLS-DAmodelling (1+1+0PCs, R2X=0.619, R2Y=0.98 andQ2=0.948) of
the 1H NMR data set from young adult wild type treatedwith RNAi targeting either phb-1 or phb-2. (B) Relative abundances of themetabolites, based on a characteristic bin, displaying an
altered content in a prohibitin-dependent manner (t-test, P-value b 0.05). Similar results were obtained for phb-1/2(RNAi) treated worms.
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complex [8–10]. Different reports have argued that PHB-1 and PHB-2
can either function together within mitochondria, in the mitochondrial
PHB complex, or have different functions in other cellular compart-
ments (reviewed in [11,35]). However, the exact function of either
PHB-1 or PHB-2 remains elusive. Herein, we show that depletion of ei-
ther PHB-1 or PHB-2 by RNAi speciﬁcally targeting each of these sub-
units has a similar effect on both the fatty acid and 1H NMR metabolic
proﬁles of otherwise wild type worms. Therefore, the results obtained
herein argue in favour of PHB-1 and PHB-2 functioning together withinthe mitochondrial prohibitin complex, and highlight the potential of
metabolomics as a functional genomics tool [36,37]. Additionally, we
show that prohibitin affects the fatty acid and 1H NMR metabolic pro-
ﬁles of otherwise wild type worms more deeply at the young adult
(YA) stage than at the fourth larval developmental (L4) stage. This indi-
cates that the metabolic proﬁles change along development in a
prohibitin-dependent manner. Since during ageing the content of fat
is altered in a prohibitin-dependent manner [6], it is likely that
prohibitin depletion leads to even more pronounced alterations on
both the fatty acid and 1H NMR metabolic proﬁles of aged worms.
Fig. 5. Prohibitin depletion alters the fatty acid composition of wild type and daf-2(e1370)worms in a similar fashion. (A) Score plot derived from the PCAmodel (3 PCs, R2X= 0.938 and
Q2 = 0.772) of the GC/FID data (control RNAi, phb-1(RNAi), daf-2(e1370); control RNAi, daf-2(e1370); phb-1(RNAi)). (B) Fatty acids with their content altered, in a similar fashion, upon
prohibitin depletion both in wild type and daf-2(e1370)worms at YA stage (t-test, P-value b 0.05). The comparison signed by * is not statistically signiﬁcant.
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tion of the metabolic network upon prohibitin depletion in otherwise
wild type worms.
The mitochondrial prohibitin complex was suggested to affect lon-
gevity by modulating mitochondrial function and fat metabolism in
C. elegans in a genetic-background-speciﬁc manner [6]. These led us to
hypothesize that the effect of prohibitin on the C. elegansmetabolome
might account for its impact in the ageing process. In agreement with
previously published data [33,38], the fatty acid composition of daf-
2(e1370)mutants is clearly different fromwild type animals. Strikingly,
prohibitin deﬁciency has an additive effect, although less pronounced,
on many of the changes observed in the loss-of-function mutant daf-
2(e1370). In particular, prohibitin deﬁciency leads to changes in the
content of polyunsaturated fatty acids (PUFAs), which have been linked
to longevity [38,39]. It was previously shown that the fatty acid chain
length and susceptibility to oxidation decreased sharply in long‐lived
mutants of the insulin like‐signalling pathway, correlating extremely
well with the lifespan of these worms [38]. In agreement with this ob-
servation, the increase in the lifespan from wild type to daf-2(e1370),
and from the later to prohibitin-depleted daf-2(e1370)worms [6] is ac-
companied by changes in the fatty acid composition that overall follow-
ed this trend, particularly a decrease in the content of long chain and
more unsaturated fatty acids. Intriguingly, the fatty acid composition
of prohibitin-depleted wild type worms, which are short-lived [6], is al-
tered in a similar fashion, having prohibitin depletion a higher impact in
the fatty acid composition of wild typeworms than of daf-2(e1370)mu-
tants. Therefore, the changes in the fatty acid composition at the YA
stage cannot, by their own, account for the opposing effect of prohibitin
on longevity. However, it is reasonable to speculate that those changescoupled to alterations in energy metabolism might have implications
in lifespan determination. Interestingly, it was found that prohibitin de-
ﬁciency extends the lifespan of both nhr-49 and fat-7mutants [6]. The
nuclear hormone receptor NHR-49 regulates fat mobilization by regu-
lating the expression of awide variety of genes, includingmitochondrial
fatty acid β-oxidation enzymes and Δ9 stearoyl-CoA desaturases, such
as FAT-7, involved in the synthesis of monounsaturated fatty acids [40].
Prohibitin deﬁciency also has a more pronounced effect on the
amino acid and carbohydrate metabolism of otherwise wild type ani-
mals than of daf-2(e1370) mutants, as assessed by 1H NMR metabolic
proﬁling. The supplementation of different amino acids can modulate
C. elegans lifespan [41]. Therefore, the widespread effect of prohibitin
depletion on amino acid metabolism deserves further investigation.
Here, wewill discuss those that seemmore promising. Prohibitin deple-
tion in otherwise wild type animals decreases the content of two
branched-chain amino acids, leucine and valine, to the levels encoun-
tered in daf-2(e1370)mutants, which were not altered upon prohibitin
depletion (Fig. 6). The content of these two amino acids in daf-2(e1370)
mutants is a matter of controversy since previously published data re-
port both higher and lower content of leucine and valine in daf-2 mu-
tants when compared to wild type worms [33,42,43]. A possible
explanation for these discrepancies could be differences in the experi-
mental designs (e.g. stage and bacterial food source) [33,42–44]. Never-
theless, in daf-2mutants the changes in the content of these amino acids
were found to be entirely DAF-16 dependent [43]. Similar to the effect
on the pool of branched amino acids, prohibitin depletion leads to a
more pronounced reduction in the content of glutamate and aspartate,
in otherwisewild typeworms than indaf-2(e1370)mutants. Glutamate,
through its role in aminotransferase reactions, is at the crossroads of
Fig. 6. 1HNMRmetabolic proﬁling of wild type and daf-2(e1370)worms upon prohibitin-depletion. (A) Score plot derived from the PCAmodelling (3 PCs, R2X=0.674 and Q2=0.431) of
the 1H NMR data (control RNAi, phb-1(RNAi), daf-2(e1370); control RNAi, daf-2(e1370); phb-1(RNAi). (B) Relative abundances of the metabolites, based on a characteristic bin, displaying
an altered content upon prohibitin depletion. (C) Model on how changes on the wormmetabolome upon prohibitin depletion might lead to opposing effects on longevity. See detailed
explanation in the main text of the discussion. ROS— reactive oxygen species.
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synthesis and degradation of other amino acids. Besides, glutamate me-
tabolism is important inmultiple othermetabolic pathways, and in par-
ticular in the replenishing of the tricarboxylic acid (TCA) cycle through
its oxidative deamination inmitochondria by glutamate dehydrogenaseto α-ketoglutarate (reviewed in [45]). Strikingly, α-ketoglutarate was
recently found to extend the lifespan of adult wild type worms in a
concentration-dependent manner through the modulation of ATP syn-
thase activity and independently of DAF-16 [46]. Similar to glutamate,
aspartate balances the content of the TCA cycle metabolite malate.
1466 A.B. Lourenço et al. / Biochimica et Biophysica Acta 1847 (2015) 1457–1468Previously, the levels of both glutamate and aspartate were shown to
strongly decrease inmitochondrial respiratory chainmutants [47]. Con-
sistentwith the idea that these changes are, at least partially, related to a
perturbation at level of the TCA cycle, we found that the levels of succi-
nate follows a similar trend than those two amino acids. Curiously, it has
been reported that daf-2mutants shift metabolism away from the TCA
cycle towards the glyoxylate cycle [22,43,48], a variation of the TCA
cycle that bypasses the decarboxylation steps, and which among other
things, enables the interconversion of fats and carbohydrates [49]. This
process may be required for the transport of energy between different
tissues and has been suggested to be done, among other ways, through
trehalose [50]. We identiﬁed the disaccharide trehalose as onemetabo-
lite very important in the distinction of the different metabolic proﬁles.
Trehalose is an important storage molecule that has been suggested to
be a longevity assurance sugar in C. elegans [51], and is considered to
be a stress responsive metabolite. Trehalose has been proposed to play
a role against oxidative and osmotic stresses and in protein stabilization
[52–54]. As previously described [33,43], trehalose accumulates to
higher levels in daf-2mutants than in wild type animals in a DAF-16 in-
dependent manner [43]. Prohibitin depletion induces an accumulation
of trehalose in both wild type worms and daf-2(e1370) mutants, al-
though the levels achieved in wild type worms upon prohibitin deple-
tion do not reach the trehalose levels of daf-2 mutants in the presence
of prohibitin.
Besides the shift towards the glyoxylate shunt, it has been reported
that daf-2 mutants undergo a major metabolic reorganization leading
to higher metabolic efﬁciency [51,55]. Moreover, it has been suggested
that ametabolic reorganization at the level of fermentativemetabolism,
such as lactate and pyruvate fermentation, may contribute to promote
longevity [56]. Accordingly, we ﬁnd signiﬁcant differences upon
prohibitin depletion between wild type worms and daf-2(e1370) mu-
tants in the levels of both lactate and the pyruvate-related amino acid
alanine. In particular, although the changes in either of the genetic back-
grounds are small and not statistically signiﬁcant, prohibitin depletion
has an opposing effect in the content of those two metabolites
(Fig. 6B) leading to statistically signiﬁcant differences between the
two genetic backgrounds. Strikingly, an inverse correlation between al-
anine levels and yeast chorological lifespan has been reported [34].
Moreover, it was shown that the enzyme that metabolises alanine is
critical for maintaining normal yeast lifespan [34]. Overall, the opposing
effect in the level of both lactate and the pyruvate-related amino acid al-
anine suggests a difference upon prohibitin depletion in the manage-
ment of fermentative metabolism in the two genetic backgrounds.
Further studies are needed to clarify the occurrence of an alteration in
fermentative metabolism in daf-2 mutants [57] and the impact of
prohibitin on it.
In light of the above observations, how can we understand the op-
posing effect of prohibitin on the longevity of wild type and daf-
2(e1370)mutants? Given the intertwined regulation of reproduction,
fatmetabolismand ageing [58], one possibility is that the longevity phe-
notypes elicited by prohibitin depletion are mediated by a differentially
altered germline in both genetic backgrounds. However, several evi-
dences strongly suggest otherwise. First, prohibitin depletion leads to
sterility in both wild type and insulin signalling mutants, yet conferring
opposite longevity phenotypes [6]. Second, the nuclear hormone recep-
tor NHR-49 is essential for the lifespan extension of germline-ablated
animals [59]. Nevertheless, prohibitin depletion extends the lifespan
of nhr-49 mutants [6]. Third, the nuclear hormone receptor DAF-12 is
also required for the lifespan extension of germline ablated animals
[60] and prohibitin depletion extends the lifespan of daf-2(e1370);daf-
12(m20) double mutants (our unpublished data). These observations
strongly indicate that the effect of prohibitin on longevity is indepen-
dent of the germline. The more pronounced effect of prohibitin deple-
tion on the metabolic proﬁles of wild type animals as compared to
daf-2(e1370) mutants suggests that the metabolic reorganization oc-
curred in daf-2 [22,23]makes these animals more robust to the changesinduced by prohibitin depletion. Therefore, we favour the scenario
where, in the context of a daf-2mutant reorganizedmetabolic network,
the changes induced by prohibitin depletion have a beneﬁcial and syn-
ergistic effect on the worm longevity, while having a detrimental effect
on the longevity of wild type animals (Fig. 6C). Prohibitin deﬁciency has
an impact on the fatty acid composition, amino acid and carbohydrate
metabolism on both wild type and daf-2(e1370) genetic backgrounds.
Moreover, we observe changes that are consistentwith a differential ef-
fect at the level of fermentative metabolism, which may be partially re-
sponsible for the longevity phonotypes (Fig. 6C). daf-2mutants show an
increase in mitochondrial fermentative malate dismutation, which con-
tributes to their increased lifespan expectancy [47,56,61]. Malate
dismutation in C. elegans needs the activity of the glyoxylate cycle and
fatty-acid derived acetyl-CoA [47,62]. In yeast, impairment of the elec-
tron transport chain (ETC) triggers the activity of anaplerotic pathways,
like the glyoxylate cycle and fatty acid β-oxidation, to feed intermedi-
ates into the TCA cycle [63]. Interestingly, prohibitin deﬁciency has
been linked to electron transfer impairment at complex I [64,65] and
several links between ETC complexes and prohibitins have been de-
scribed [66,67]. It has been proposed that wormmutants with an affect-
ed ETC [56], like clk-1mutants, activate fermentative metabolism in an
inefﬁcientway, while in daf-2mutants fermentativemetabolism is con-
stitutively active. Therefore, in clk-1;daf-2 double mutants there is a
powerful increase in fermentative metabolism, with a concomitant re-
duction in the generation of ROS leading to a beneﬁcial outcome in
terms of longevity [56]. In a similar way, we hypothesized that in
prohibitin-depleted daf-2 mutants there is an increase in fermentative
metabolism, while in prohibitin-depleted worms there is not (Fig. 6C).
Consistent with this idea, prohibitin depletion increased ROS levels in
otherwise wild type worms, while it decreased ROS in daf-2 mutants
[6]. Thus, a plausible explanation for the synergetic effect of prohibitin
depletion on the longevity of daf-2mutants is the observed additive ef-
fect of prohibitin depletion in the fatty acid composition of daf-2(e1370)
mutants, which in the context of a reorganized metabolic network,
namely a more efﬁcient fermentative metabolism, may contribute to
the positive outcome in terms of longevity (Fig. 6C). Nevertheless, we
do not rule out the possibility of a differential effect on other meta-
bolic pathways and/or speciﬁc classes of lipids. The differences in
longevity outcome might also be understood in the scope of the ob-
servation that prohibitin deﬁciency has a strong effect on glutamate
metabolism, which has been shown to be linked to insulin secretion
in β-cells through glutamate dehydrogenase [68–70]. Thus, if this
connection also exists in C. elegans, the strong effect of prohibitin in
the levels of glutamate observed in both genetic backgrounds may
give a plausible metabolic connection between prohibitin and the
IIS pathway. The same effect of prohibitin in the levels of glutamate
may have a complete different outcome in animals with an intact
or with a compromised IIS pathway, with implications on the longevity
of the worms.
5. Conclusion
The effect of prohibitin depletion on the fatty acid and 1H NMRmet-
abolic proﬁles of wholeworm extracts revealed broadmetabolic chang-
es. RNAi targeting either phb-1 or phb-2 had a similar effect on the
metabolic proﬁles of otherwise wild type worms, arguing in favour of
PHB-1 and PHB-2 functioning together within the mitochondrial
prohibitin complex. Moreover, the alterations induced by prohibitin de-
pletion in themetabolic proﬁles of otherwisewild typeworms, suggests
that along time the metabolome changes in a prohibitin-dependent
manner. Strikingly, prohibitin depletion affects more deeply fatty acid
composition, and amino acid and carbohydrate metabolism in other-
wise wild type than in daf-2 mutant worms. Additionally, RNAi
targeting of phb-1 in daf-2 mutants had an additive effect in some of
the changes observed in the metabolic proﬁle of daf-2 mutants com-
pared to wild type animals. Altogether, this work adds signiﬁcant data
1467A.B. Lourenço et al. / Biochimica et Biophysica Acta 1847 (2015) 1457–1468that provide crucial insights to understand how mitochondria and the
insulin/insulin-like signalling pathway interact to determine longevity.
Moreover, it stresses the importance of further metabolic studies, in-
volving more global mass spectrometry-based approaches, to obtain a
more complete picture of the metabolic changes elicited to prolong
life. Herein, we describe the ﬁrst global molecular characterisation of
the effect of prohibitin in the C. elegans metabolome, providing ex-
tremely valuable molecular insights towards understanding the oppos-
ing effect of prohibitin depletion in longevity.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbabio.2015.06.003.
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